HCR Wealth Advisors

SEC CIK: 0001697715
Latest filing: Jul 13, 2026

SEC filings (opens in a new tab)

INBX holding history

Inhibrx Biosciences, Inc. in every 13F filed by HCR Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INBX overview All 13F holders of INBX Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of INBX by HCR Wealth Advisors, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−6,300−100.0%	Sold out	Holders
Q1 2024	6,300	$220.2K	<0.1%	00.0%	Unchanged	Holders
Q4 2023	6,300	$239.4K	<0.1%	+6,300	New	Holders